Lyra Therapeutics, Inc. (LYRA)
1.49
+0.09
(+6.43%)
USD |
NASDAQ |
Feb 19, 16:00
1.42
-0.07
(-4.70%)
Pre-Market: 20:00
Lyra Therapeutics Shareholders Equity (Quarterly) : -4.328M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 5.054M |
| BioStem Technologies, Inc. | 50.02M |
| Iovance Biotherapeutics, Inc. | 702.29M |
| Protokinetix, Inc. | 0.2504M |
| GB Sciences, Inc. | -5.88M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.71M |
| Total Liabilities (Quarterly) | 48.04M |
| Debt to Equity Ratio | -7.250 |
| Current Ratio | 2.428 |
| Net Debt Paydown Yield | 12.42% |